Sansure Biotech Inc.

SHSE:688289 Rapporto sulle azioni

Cap. di mercato: CN¥12.9b

Sansure Biotech Gestione

Gestione criteri di controllo 4/4

Sansure Biotech Il CEO è Lizhong Dai, nominato in Jul2019, ha un mandato di 5.33 anni. possiede direttamente 33.21% delle azioni della società, per un valore di CN¥ 4.27B. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.3 anni e 5.3 anni.

Informazioni chiave

Lizhong Dai

Amministratore delegato

CN¥700.6k

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO5.3yrs
Proprietà del CEO33.2%
Durata media del management5.3yrs
Durata media del Consiglio di amministrazione5.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Sansure Biotech's (SHSE:688289) Problems Go Beyond Weak Profit

Nov 03
Sansure Biotech's (SHSE:688289) Problems Go Beyond Weak Profit

Sansure Biotech Inc.'s (SHSE:688289) 39% Price Boost Is Out Of Tune With Earnings

Oct 09
Sansure Biotech Inc.'s (SHSE:688289) 39% Price Boost Is Out Of Tune With Earnings

Sansure Biotech (SHSE:688289) Could Be Struggling To Allocate Capital

Oct 03
Sansure Biotech (SHSE:688289) Could Be Struggling To Allocate Capital

Is Sansure Biotech (SHSE:688289) A Risky Investment?

Sep 12
Is Sansure Biotech (SHSE:688289) A Risky Investment?

Sansure Biotech Inc. (SHSE:688289) Investors Are Less Pessimistic Than Expected

Aug 21
Sansure Biotech Inc. (SHSE:688289) Investors Are Less Pessimistic Than Expected

Sansure Biotech (SHSE:688289) May Have Issues Allocating Its Capital

Jun 03
Sansure Biotech (SHSE:688289) May Have Issues Allocating Its Capital

Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems

May 03
Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems

Sansure Biotech Inc.'s (SHSE:688289) Business Is Trailing The Industry But Its Shares Aren't

Apr 26
Sansure Biotech Inc.'s (SHSE:688289) Business Is Trailing The Industry But Its Shares Aren't

Sansure Biotech's (SHSE:688289) Returns On Capital Are Heading Higher

Feb 28
Sansure Biotech's (SHSE:688289) Returns On Capital Are Heading Higher

AMMINISTRATORE DELEGATO

Lizhong Dai (56 yo)

5.3yrs

Mandato

CN¥700,600

Compensazione

Mr. Lizhong Dai is Chairman of the Board and General Manager of Sansure Biotech Inc. from July 2019.


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Lizhong Dai
Chairman of the Board & GM5.3yrsCN¥700.60k33.21%
CN¥ 4.3b
Zhu Peng
CFO, Deputy GM & Director5.3yrsCN¥1.68m0.067%
CN¥ 8.6m
Peng Yin
Deputy GM1.8yrsCN¥2.28mNessun dato
Xialin Yu
Deputy GM & Director5.3yrsCN¥439.70k0.026%
CN¥ 3.4m
Xu Fan
Deputy GM & Director5.3yrsCN¥666.90k0.054%
CN¥ 6.9m
Jia Liu
Deputy GM & Directorno dataCN¥557.80k0.035%
CN¥ 4.5m
Jun Zhou
Deputy General Manager5.3yrsCN¥970.40k0.016%
CN¥ 2.0m
Kai Liu
Deputy General Manager3.3yrsCN¥1.55m0.026%
CN¥ 3.3m
Jian Zhu
Deputy General Manager3.3yrsCN¥2.34m0.025%
CN¥ 3.2m
Zhongping Deng
Deputy General Manager5.3yrsCN¥522.60k0.019%
CN¥ 2.4m
Haixiao Wang
Deputy General Manager2.3yrsCN¥1.43m0.041%
CN¥ 5.2m
Xiaoyan Xiong
Deputy General Manager2.1yrsCN¥621.60k0.022%
CN¥ 2.8m

5.3yrs

Durata media

47yo

Età media

Gestione esperta: Il team dirigenziale di 688289 è esperto e expertise (durata media dell'incarico 5.3 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Lizhong Dai
Chairman of the Board & GM5.3yrsCN¥700.60k33.21%
CN¥ 4.3b
Zhu Peng
CFO, Deputy GM & Director4.8yrsCN¥1.68m0.067%
CN¥ 8.6m
Xialin Yu
Deputy GM & Director5.3yrsCN¥439.70k0.026%
CN¥ 3.4m
Xu Fan
Deputy GM & Director4.1yrsCN¥666.90k0.054%
CN¥ 6.9m
Jia Liu
Deputy GM & Director2.3yrsCN¥557.80k0.035%
CN¥ 4.5m
Wu Tan
Chairman of Supervisory Board5.3yrsNessun dato0.035%
CN¥ 4.5m
Ya Cao
Independent Director5.3yrsCN¥80.00kNessun dato
Yuan Fang
Director5.3yrsNessun datoNessun dato
Ling Lin
Supervisor2.3yrsNessun dato0.00040%
CN¥ 51.4k

5.3yrs

Durata media

45yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 688289 sono considerati esperti (durata media dell'incarico 5.3 anni).